BriaCell Therapeutics Corp. (BCTX) Form 8-K — Jun 2, 2026
$BCTXForm 8-KItems 1.01, 3.02, 8.01, 9.01Filed Jun 2, 2026, 9:32 PM ET0001493152-26-026953Original filing
BriaCell Therapeutics Corp. (BCTX) announced the closing of a best-efforts private placement offering on June 2, 2026. The company sold 1,449,300 common shares at a price of $3.25 per share, generating gross proceeds of approximately $4.71 million. The offering was conducted pursuant to an existing shelf registration statement (Form S-3) filed in January 2024.
Key figures
- Gross Proceeds
- 4710225
- Offering Price
- 3.25
- Shares Offered
- 1449300
- Warrant Exercise Price
- 4.0625
- Placement Agent Warrants
- 72465
- Placement Agent Fee Percent
- 7.5
Price after filing
1 day: +1.2%7 days: -6.1%30 days: +6.1%
Close on the filing date to close N calendar days later (from $3.27). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.